Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Hspg2em1flox/Cya
Common Name:
Hspg2-flox
Product ID:
S-CKO-02997
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Hspg2-flox
Strain ID
CKOCMP-15530-Hspg2-B6J-VA
Gene Name
Hspg2
Product ID
S-CKO-02997
Gene Alias
HSPG; Pcn; Plc; per
Background
C57BL/6JCya
NCBI ID
15530
Modification
Conditional knockout
Chromosome
4
Phenotype
MGI:96257
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Hspg2em1flox/Cya mice (Catalog S-CKO-02997) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000171332
NCBI RefSeq
NM_008305
Target Region
Exon 2~3
Size of Effective Region
~1.9 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Hspg2, also known as heparan sulfate proteoglycan 2, encodes perlecan, a multifunctional proteoglycan crucial for extracellular matrix integrity, tissue border maintenance, and regulation of various signaling pathways. It plays significant roles in many developmental processes like heart and brain formation, and is widely expressed in the musculoskeletal system [2].

In hypertrophic scar formation, TNFSF13 activates the NF-κB signaling pathway by interacting with Hspg2, regulating the proliferation, migration, fibrosis, and inflammatory response of hypertrophic scar fibroblasts. Mesenchymal stem cell-derived exosomes alleviate hypertrophic scar by inhibiting fibroblasts via the TNFSF-13/Hspg2 signaling pathway [1].

In human cardiomyocytes, perlecan (Hspg2 product) promotes structural, contractile, and metabolic development. Haploinsufficiency of Hspg2 in late-stage cardiomyocytes leads to structural, contractile, metabolic, and ECM gene dysregulation [3].

In bladder cancer, Hspg2 promotes tumor progression through the NID1/AKT signaling pathway [4].

In acute myeloid leukemia, Hspg2 overexpression is associated with poor prognosis and can be an independent prognostic biomarker [5].

Mutations in Hspg2 are associated with better immune checkpoint inhibitor outcomes in melanoma and non-small cell lung cancer, likely due to favorable immunocyte abundance and mutational burden [6].

Hspg2 may be a modifier gene for Marfan syndrome, as its expression correlates with disease severity in a mouse model [7].

Mutations in Hspg2 cause Schwartz-Jampel syndrome type 1, a rare musculoskeletal disorder [8].

Polymorphisms in Hspg2 are associated with intracranial aneurysm susceptibility [9].

In pan-cancer analysis, Hspg2 shows potential as a diagnostic and prognostic marker for bladder urothelial carcinoma and mesothelioma [10].

In conclusion, Hspg2 is essential for multiple biological processes, from development to tissue-specific functions. Its dysregulation or mutation is linked to various diseases, including fibrotic, cardiac, cancerous, and musculoskeletal disorders. Studies on Hspg2, often through mouse models, contribute to understanding disease mechanisms and developing potential therapeutic strategies for these conditions.

References:
1. Zhang, Huimin, Zang, Chengyu, Zhao, Wen, Wu, Jie, Cui, Rongtao. 2023. Exosome Derived from Mesenchymal Stem Cells Alleviates Hypertrophic Scar by Inhibiting the Fibroblasts via TNFSF-13/HSPG2 Signaling Pathway. In International journal of nanomedicine, 18, 7047-7063. doi:10.2147/IJN.S433510. https://pubmed.ncbi.nlm.nih.gov/38046235/
2. Martinez, Jerahme R, Dhawan, Akash, Farach-Carson, Mary C. 2018. Modular Proteoglycan Perlecan/HSPG2: Mutations, Phenotypes, and Functions. In Genes, 9, . doi:10.3390/genes9110556. https://pubmed.ncbi.nlm.nih.gov/30453502/
3. Johnson, Benjamin B, Cosson, Marie-Victoire, Tsansizi, Lorenza I, Bernardo, Andreia S, Smith, James G W. 2024. Perlecan (HSPG2) promotes structural, contractile, and metabolic development of human cardiomyocytes. In Cell reports, 43, 113668. doi:10.1016/j.celrep.2023.113668. https://pubmed.ncbi.nlm.nih.gov/38198277/
4. Li, Cong, Luo, Pengwei, Guo, Fengzhu, Wang, Shusen, Du, Ting. 2024. Identification of HSPG2 as a bladder pro-tumor protein through NID1/AKT signaling. In Cancer cell international, 24, 345. doi:10.1186/s12935-024-03527-7. https://pubmed.ncbi.nlm.nih.gov/39438949/
5. Zhou, Xiaojia, Liang, Simin, Zhan, Qian, Chi, Jianxiang, Wang, Li. 2020. HSPG2 overexpression independently predicts poor survival in patients with acute myeloid leukemia. In Cell death & disease, 11, 492. doi:10.1038/s41419-020-2694-7. https://pubmed.ncbi.nlm.nih.gov/32606327/
6. Zhang, Wenjing, Lin, Zhijuan, Shi, Fuyan, Wang, Suzhen, Wang, Qinghua. 2022. HSPG2 Mutation Association with Immune Checkpoint Inhibitor Outcome in Melanoma and Non-Small Cell Lung Cancer. In Cancers, 14, . doi:10.3390/cancers14143495. https://pubmed.ncbi.nlm.nih.gov/35884556/
7. Gerdes Gyuricza, Isabela, Barbosa de Souza, Rodrigo, Farinha-Arcieri, Luis Ernesto, Ribeiro Fernandes, Gustavo, Veiga Pereira, Lygia. 2020. Is HSPG2 a modifier gene for Marfan syndrome? In European journal of human genetics : EJHG, 28, 1292-1296. doi:10.1038/s41431-020-0666-0. https://pubmed.ncbi.nlm.nih.gov/32514132/
8. Brugnoni, Raffaella, Marelli, Daria, Iacomino, Nicola, Maggi, Lorenzo, Ardissone, Anna. 2023. Novel HSPG2 Gene Mutation Causing Schwartz-Jampel Syndrome in a Moroccan Family: A Literature Review. In Genes, 14, . doi:10.3390/genes14091753. https://pubmed.ncbi.nlm.nih.gov/37761893/
9. Liu, Huahui, Huang, Wen. . The Association between Genes Polymorphisms of Heparan Sulfate Proteoglycan 2 (HSPG2) and Chondroitin Sulfate Proteoglycan 2 (CSPG2) and Intracranial Aneurysm Susceptibility: A Meta-Analysis. In Iranian journal of public health, 48, 1945-1951. doi:. https://pubmed.ncbi.nlm.nih.gov/31970092/
10. Chen, Fangjun, Gu, Xing, Qiang, Guangliang. 2025. Comprehensive pan-cancer analysis of HSPG2 as a marker for prognosis. In BMC medical genomics, 18, 33. doi:10.1186/s12920-025-02103-w. https://pubmed.ncbi.nlm.nih.gov/39956899/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest